Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism

NCT00743782 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Hypoparathyroidism
Hypocalcemia
Autoimmune Polyendocrine Syndrome Type 1
Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Interventions

DRUG: Synthetic Human Parathyroid Hormone 1-34 pump

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]